Low-Level Zoonotic Transmission of Clade C MERS-CoV in Africa: Insights from Scoping Review and Cohort Studies in Hospital and Community Settings
Viruses · 2025
DOI: 10.3390/v17010125 ↗Kurz gefasst
Scoping Review in der Zeitschrift Viruses, 2025. Verfasst von Andrew Karani und 7 weiteren Autor:innen. Beteiligte Einrichtung: Global Health Program, Washington State University Global Health-Kenya, Nairobi 00200, Kenya. Hauptthemen laut MEDLINE: Middle East Respiratory Syndrome Coronavirus, Zoonoses, Coronavirus Infections. Die Arbeit wurde bisher 14-mal zitiert (Crossref) und nennt 39 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: FIC NIH HHS, NIAID NIH HHS, National Institutes of Health through the Centre for Research in Emerging Infectious Diseases-East and Central Africa (CREID-ECA).
Abstract (Originalsprache)
Human outbreaks of Middle East respiratory syndrome coronavirus (MERS-CoV) are more common in Middle Eastern and Asian human populations, associated with clades A and B. In Africa, where clade C is dominant in camels, human cases are minimal. We reviewed 16 studies (n = 6198) published across seven African countries between 2012 and 2024 to assess human MERS-CoV cases. We also analyzed data from four cohort studies conducted in camel-keeping communities between 2018 and 2024 involving camel keepers, camel slaughterhouse workers, and hospital patients with acute respiratory illness (ARI). The analysis showed a pooled MERS-CoV prevalence of 2.4% (IQR: 0.6, 11.4) from 16 publications and 1.14% from 4 cohort studies (n = 2353). Symptomatic cases were rarely reported, with most individuals reporting camel contact, and only 12% had travel history to the Middle East. There was one travel-associated reported death, resulting in a mortality rate of 0.013%. The findings suggest a low camel-to-human transmission of clade C MERS-CoV in Africa. Ongoing research focuses on genomic comparisons between clade C and the more virulent clades A and B, alongside the surveillance of viral evolution. This study highlights the need for continuous monitoring but indicates that MERS-CoV clade C currently poses a minimal public health threat in Africa.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Global Health Program, Washington State University Global Health-Kenya, Nairobi 00200, Kenya.
- Department of Medical Microbiology, University of Nairobi, Nairobi 00200, Kenya.
- Rollins School of Public Health, Emory University, Atlanta, GA 30322, USA.
- Paul G Allen School of Global Health, Washington State University, Pullman, WA 98165, USA.
ORCID-Profile: Cynthia Ombok, Silvia Situma, Marianne Mureithi
Förderung
- FIC NIH HHS
- NIAID NIH HHS
- National Institutes of Health through the Centre for Research in Emerging Infectious Diseases-East and Central Africa (CREID-ECA)
- NIH/Fogarty International Center's D43 training grant
- Ministries of Health and county governments of Isiolo and Marsabit
- US National Institute of Allergy and Infectious Disease/National Institutes of Health (NIAID/NIH)
- NIH/Fogarty International Center’s D43 training
Zitieren
APA
Karani, A., Ombok, C., Situma, S., Breiman, R., Mureithi, M., Jaoko, W., Njenga, M. K., & Ngere, I. (2025). Low-Level Zoonotic Transmission of Clade C MERS-CoV in Africa: Insights from Scoping Review and Cohort Studies in Hospital and Community Settings. Viruses. https://doi.org/10.3390/v17010125
Vancouver
Karani A, Ombok C, Situma S, Breiman R, Mureithi M, Jaoko W, et al. Low-Level Zoonotic Transmission of Clade C MERS-CoV in Africa: Insights from Scoping Review and Cohort Studies in Hospital and Community Settings. Viruses. 2025. doi:10.3390/v17010125
BibTeX
@article{Karani2025,
author = {Karani, Andrew and Ombok, Cynthia and Situma, Silvia and Breiman, Robert and Mureithi, Marianne and Jaoko, Walter and Njenga, M Kariuki and Ngere, Isaac},
title = {Low-Level Zoonotic Transmission of Clade C MERS-CoV in Africa: Insights from Scoping Review and Cohort Studies in Hospital and Community Settings},
journal = {Viruses},
year = {2025},
doi = {10.3390/v17010125}
}
EUVIMED